NCT02508870 A Study of Atezolizumab Administered Alone or in Combination With Azacitidine in Participants With Myelodysplastic Syndromes Status COMPLETED Phase PHASE1
NCT02508090 Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin Status COMPLETED Phase N/A
NCT02507752 An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab Status COMPLETED Phase N/A
NCT02507375 A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1
NCT02498275 Effect of RO6871765 and RO7011785 on Immune Response With the Stimulation of Peripheral Blood Mononuclear Cells (PBMCs) in Chinese Healthy Volunteers and Chronic Hepatitis B Patients Status TERMINATED Phase N/A
NCT02494596 A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02491892 A Study of Pertuzumab in Participants With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT02490514 A Study Of Mircera In Patients With Kidney Disease Who Are Not On Dialysis Status COMPLETED Phase N/A
NCT02490475 A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02488330 An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study Status COMPLETED Phase PHASE3
NCT02486952 MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma Status COMPLETED Phase N/A
NCT02486718 Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02485483 Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) Participants Status COMPLETED Phase N/A
NCT02484703 A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age Status TERMINATED Phase PHASE2
NCT02484690 A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) Status COMPLETED Phase PHASE2
NCT02480010 A Study of Pertuzumab in Participants With Prostate Cancer Status TERMINATED Phase PHASE2
NCT02479386 A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Status TERMINATED Phase N/A
NCT02477059 Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis Status COMPLETED Phase PHASE3
NCT02476942 A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment Status COMPLETED Phase N/A